Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China.
Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200011, China.
Stem Cell Reports. 2018 Feb 13;10(2):509-523. doi: 10.1016/j.stemcr.2018.01.001. Epub 2018 Feb 1.
Due to differences across species, the mechanisms of cell fate decisions determined in mice cannot be readily extrapolated to humans. In this study, we developed a feeder- and xeno-free culture protocol that efficiently induced human pluripotent stem cells (iPSCs) into PLZF+/GPR125+/CD90+ spermatogonium-like cells (SLCs). These SLCs were enriched with key genes in germ cell development such as MVH, DAZL, GFRα1, NANOS3, and DMRT1. In addition, a small fraction of SLCs went through meiosis in vitro to develop into haploid cells. We further demonstrated that this chemically defined induction protocol faithfully recapitulated the features of compromised germ cell development of PSCs with NANOS3 deficiency or iPSC lines established from patients with non-obstructive azoospermia. Taken together, we established a powerful experimental platform to investigate human germ cell development and pathology related to male infertility.
由于物种间的差异,在小鼠中确定的细胞命运决定机制不能轻易外推到人类。在这项研究中,我们开发了一种无饲养层和异种细胞的培养方案,能够有效地将人多能干细胞(iPSC)诱导为 PLZF+/GPR125+/CD90+精原细胞样细胞(SLC)。这些 SLC 富集了关键基因,如生殖细胞发育中的 MVH、DAZL、GFRα1、NANOS3 和 DMRT1。此外,一小部分 SLC 经历了减数分裂,在体外发育成单倍体细胞。我们进一步证明,这种化学定义的诱导方案忠实地再现了 NANOS3 缺陷的 PSCs 或从非梗阻性无精子症患者建立的 iPSC 系中受损的生殖细胞发育的特征。总之,我们建立了一个强大的实验平台,用于研究人类生殖细胞发育和与男性不育相关的病理学。